ArticleFrontiers in pediatrics2026
Global research trends in biliary atresia-related liver fibrosis: a bibliometric analysis (2000-2024).
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Biliary atresia (BA) is a severe neonatal liver disorder that can progress to liver fibrosis and eventual failure. This bibliometric study evaluates global research on BA-related liver fibrosis from 2000 to 2024, highlighting emerging trends and key contributions. Methods: Data were retrieved from the Web of Science Core Collection, focusing on original articles and reviews. Bibliometric tools were employed to assess publication trends, citation impact, and research collaboration. Results: A total of 589 publications were identified from 2000 to 2024. Publication output showed relative stability from 2000 to 2014 (223 publications), followed by a marked increase to 296 publications during 2015-2022, with continued growth in 2023 (39 publications) and 2024 (31 publications) [ Conclusion: Research on BA-related liver fibrosis has significantly increased, with key contributions from leading countries, institutions, and authors. Core journals have been instrumental in shaping the research discourse. This study provides valuable insights into current research trends and future directions, emphasizing the importance of interdisciplinary collaboration in advancing the understanding and treatment of BA-related liver fibrosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.